Table 3.
Platform | Rationale | Advantages | Disadvantages |
---|---|---|---|
Nucleic acid method | Epithelial/Tumor/Tissue-specific antigen |
|
|
Flow cytometery | Positive selection of Epithelial-specific antigen Negative depletion of leukocytes |
|
|
CellSearch (Veridex) | Positive selection of EpCAM/CK Negative depletion of CD45 |
|
CTC without epithelial marker could not be detected |
CTC Chip | Positive selection of EpCAM/CK |
|
Technology is not commercially available |